Menu
Currency
GWAS Study

Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.

Ikeda M, Takahashi A, Kamatani Y et al.

30285260 PubMed ID
GWAS Study Type
67889 Participants
114 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

IM
Ikeda M
TA
Takahashi A
KY
Kamatani Y
MY
Momozawa Y
ST
Saito T
KK
Kondo K
SA
Shimasaki A
KK
Kawase K
ST
Sakusabe T
IY
Iwayama Y
TT
Toyota T
WT
Wakuda T
KM
Kikuchi M
KN
Kanahara N
YH
Yamamori H
YY
Yasuda Y
WY
Watanabe Y
HS
Hoya S
AB
Aleksic B
KI
Kushima I
AH
Arai H
TM
Takaki M
HK
Hattori K
KH
Kunugi H
OY
Okahisa Y
OT
Ohnuma T
ON
Ozaki N
ST
Someya T
HR
Hashimoto R
YT
Yoshikawa T
KM
Kubo M
IN
Iwata N
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies (GWASs) have identified >100 susceptibility loci for schizophrenia (SCZ) and demonstrated that SCZ is a polygenic disorder determined by numerous genetic variants but with small effect size. We conducted a GWAS in the Japanese (JPN) population (a) to detect novel SCZ-susceptibility genes and (b) to examine the shared genetic risk of SCZ across (East Asian [EAS] and European [EUR]) populations and/or that of trans-diseases (SCZ, bipolar disorder [BD], and major depressive disorder [MDD]) within EAS and between EAS and EUR (trans-diseases/populations). Among the discovery GWAS subjects (JPN-SCZ GWAS: 1940 SCZ cases and 7408 controls) and replication dataset (4071 SCZ cases and 54479 controls), both comprising JPN populations, 3 novel susceptibility loci for SCZ were identified: SPHKAP (Pbest = 4.1 × 10-10), SLC38A3 (Pbest = 5.7 × 10-10), and CABP1-ACADS (Pbest = 9.8 × 10-9). Subsequent meta-analysis between our samples and those of the Psychiatric GWAS Consortium (PGC; EUR samples) and another study detected 12 additional susceptibility loci. Polygenic risk score (PRS) prediction revealed a shared genetic risk of SCZ across populations (Pbest = 4.0 × 10-11) and between SCZ and BD in the JPN population (P ~ 10-40); however, a lower variance-explained was noted between JPN-SCZ GWAS and PGC-BD or MDD within/across populations. Genetic correlation analysis supported the PRS results; the genetic correlation between JPN-SCZ and PGC-SCZ was ρ = 0.58, whereas a similar/lower correlation was observed between the trans-diseases (JPN-SCZ vs JPN-BD/EAS-MDD, rg = 0.56/0.29) or trans-diseases/populations (JPN-SCZ vs PGC-BD/MDD, ρ = 0.38/0.12). In conclusion, (a) Fifteen novel loci are possible susceptibility genes for SCZ and (b) SCZ "risk" effect is shared with other psychiatric disorders even across populations.

1,940 Japanese ancestry cases, 7,408 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

67889
Total Participants
GWAS
Study Type
Yes
Replicated
4,071 Japanese ancestry cases, 54,470 Japanese ancestry controls
Replication Participants
East Asian, European
Ancestry
Japan
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.